Supplementary Figure S9 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Tanner Michael Johanns; Elizabeth A.R. Garfinkle; Katherine E. Miller; Alexandra J. Livingstone; Kaleigh F. Roberts; Lakshmi P. Rao Venkata; Joshua L. Dowling; Michael R. Chicoine; Ralph G. Dacey; Gregory Joseph Zipfel; Albert H. Kim; Elaine R. Mardis; Gavin P. Dunn

doi:10.1158/1078-0432.31085053

Supplementary Figure S9 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

2026 Open access

Read full text

Authors: Tanner Michael Johanns, Elizabeth A.R. Garfinkle, Katherine E. Miller, Alexandra J. Livingstone, Kaleigh F. Roberts, Lakshmi P. Rao Venkata, Joshua L. Dowling, Michael R. Chicoine, Ralph G. Dacey, Gregory Joseph Zipfel, Albert H. Kim, Elaine R. Mardis

+1 more

Gavin P. Dunn

DOI: 10.1158/1078-0432.31085053

Cited by: 0

Abstract

Bar graph displaying number of validated variants for each subject

Fields of Study & Subjects

Glioma Diagnosis and Treatment vaccines and immunoinformatics approaches Cancer Immunotherapy and Biomarkers

Publication details

Publication date: 19 January 2026